...
机译:oa08.01通过NMS脑脊液中NSCLC患者的百叶菌转移潜在机制探讨
Chemotherapy Zhejiang Cancer Hospital;
Asia &
Emerging Markets Imed astrazeneca Innovative Medicine and Early Development;
Asia &
Emerging Markets Imed Astrazeneca Innovative Medicine and Early Development;
Department of Respiratory Medicine Peking Union Medical College Hospital Chinese Academy of;
Chemotherapy Zhejiang Cancer Hospital;
Asia &
Emerging Markets Imed astrazeneca Innovative Medicine and Early Development;
Asia &
Emerging Markets Imed astrazeneca Innovative Medicine and Early Development;
Asia &
Emerging Markets Imed astrazeneca Innovative Medicine and Early Development;
Asia &
Emerging Markets Imed astrazeneca Innovative Medicine and Early Development;
Zhejiang Cancer Hospital key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology;
Zhejiang Cancer Hospital key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology;
Zhejiang Cancer Hospital key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology;
Zhejiang Cancer Hospital key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology;
Zhejiang Cancer Hospital key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology;
Zhejiang Cancer Hospital key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology;
机译:oa08.01通过NMS脑脊液中NSCLC患者的百叶菌转移潜在机制探讨
机译:P2.01-52 NSCLC患者脑脊液中脑膜母细胞组织特异性外泌体miRNA签名的鉴定
机译:来自脑脊液的无细胞DNA的遗传分析:在EGFR-突变体NSCLC中打开百分之育膜转移的屏障
机译:在F-18-FDG PET / CT上的非小型细胞肺癌(NSCLC)患者中淋巴结转移的自动分类
机译:多发性硬化症患者外周血和脑脊液中产生的γT细胞:细胞毒性机制,抑制性自然杀伤细胞受体和蛋白质分析。
机译:脑脊液代谢组学特征可将脑膜脑膜癌患者与脑膜脑膜转移高风险患者区分开
机译:脑脊液代谢物谱可以区分患者患者患者患者患者的患者患者患者肌瘤转移